Sign in
CompletedPhase 1

Feasibility of a Digital Therapeutic for Adults With Posttraumatic Stress Disorder (PTSD)

Key facts

Who runs it
Oui Therapeutics, Inc.
Where
Tallahassee, United StatesSee the site
Trial code
Status
Completed
Phase
Phase 1
People taking part
40 people enrolled
Started
30 Jun 2025
Ended
21 Nov 2025
Type of study
Interventional, 2 groups
Treatments tested
  • OTX-601 Digital Therapeutic - Version 1
  • OTX-601 Digital Therapeutic - Version 2
  • Treatment as Usual (TAU)
Record updated
27 July 2026

Who can take part

Age
18 years and older
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 12 criteriaShow less

Who can take part

  • Posttraumatic stress disorder (PTSD) diagnosis
  • Anxiety Sensitivity Index 3 (ASI-3) scores above 24
  • PTSD Checklist for DSM-V (PCL-5) scores above 30
  • Understands and speaks English
  • Access to a smartphone that is connected to the internet

Who cannot take part

  • Medical illness that would prevent the completion of interoceptive exposure exercises
  • Score of 24 or lower on the ASI-3
  • Score of 30 and below on the PCL-5
  • No PTSD diagnosis
  • Active psychosis
  • Acute intoxication during study baseline
  • Enrolled in another treatment research study

Where in United States

  • Florida State UniversityTallahassee, United States

About the trial

What the trial wants to find out

This study is exploring the efficacy of a digital therapeutic app in reducing symptoms of posttraumatic stress disorder (PTSD) in adults.

The 2 groups in the trial

  • OTX-601 Digital Therapeutic - Version 1Treatment being tested

    A prescription digital therapeutic designed to overcome existing barriers and deliver evidence-based treatment for PTSD

    Treatment: OTX-601 Digital Therapeutic - Version 1 and Treatment as Usual (TAU)

  • OTX-601 Digital Therapeutic - Version 2Treatment being tested

    Increased dose of a prescription digital therapeutic designed to overcome existing barriers and deliver evidence-based treatment for PTSD

    Treatment: OTX-601 Digital Therapeutic - Version 2 and Treatment as Usual (TAU)

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Dosage, Feasibility, Acceptability and Usability of OTX-601
Record updated
27 July 2026